
A Rapid, Culture-Free Method to Determine 50% Neutralization Titer (NT50) Using the ACE2-Competitive Bio-Plex Pro SARS-CoV-2 Neutralization Antibody Assay

Scalable Purification Strategies for Viral Vectors and Vaccines

Maximizing Metastasis Insights with a Novel Integrated Workflow for CTC Enrichment and Enumeration

Generating Anti-CD19 CAR T Cells with High Efficiency and Viability via mRNA Electroporation

Downstream Process Development for the Purification of Biosimilar Insulin from Escherichia coli

Learn to Develop a New Multiplex SARS-CoV-2 Variant Neutralizing Antibody Assay in a Single Day

Purification of DNA Oligonucleotides using Anion Exchange Chromatography

High Performance with GMP Ready CHT Prepacked Process-Scale Columns

Generation of Recombinant Tool Antibodies to Support Cell and Gene Therapy Development
